.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Covington
Dow
Daiichi Sankyo
Mallinckrodt
McKesson
Merck
Cantor Fitzgerald
Moodys
McKinsey

Generated: June 24, 2017

DrugPatentWatch Database Preview

VIBISONE Drug Profile

« Back to Dashboard

What is the patent landscape for Vibisone, and when can generic versions of Vibisone launch?

Vibisone is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in VIBISONE is cyanocobalamin. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Summary for Tradename: VIBISONE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIBISONE at DailyMed

Pharmacology for Tradename: VIBISONE

Ingredient-typeVitamin B 12
Drug ClassVitamin B12
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
VIBISONE
cyanocobalamin
INJECTABLE;INJECTION080557-003Approved Prior to Jan 1, 1982APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Colorcon
Federal Trade Commission
Fish and Richardson
Covington
Moodys
Harvard Business School
Chinese Patent Office
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot